#clinical trial

Heart Drug Slashed ‘Bad Fat’ 78% But Saved No Lives

Pelacarsen cut the heart-risk particle Lp(a) by 78% in more than 8,300 patients, yet prevented no heart attacks or strokes, researchers reported on Saturday.